Stockholders’ Equity - Schedule of Common Stock Warrant Activity (Details) $ / shares in Units, $ in Thousands |
6 Months Ended |
---|---|
Jun. 30, 2022
USD ($)
$ / shares
shares
| |
Weighted-average Exercise price per share | |
Beginning balance (in dollars per share) | $ / shares | $ 2.97 |
Exercised (in dollars per share) | $ / shares | 2.20 |
Terminated (in dollars per share) | $ / shares | 2.20 |
Ending balance (in dollars per share) | $ / shares | $ 16.23 |
Intrinsic Value | |
Outstanding, intrinsic value | $ | $ 0 |
Common Stock Warrants | |
Restricted Stock | |
Outstanding, beginning balance (in shares) | shares | 668,907 |
Exercised (in shares) | shares | (462,353) |
Terminated (in shares) | shares | 170,000 |
Outstanding, ending balance (in shares) | shares | 36,554 |
X | ||||||||||
- Definition Weighted average price per share for warrants exercised during the period. No definition available.
|
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-average Exercise Price Per Share No definition available.
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the other than stock option plan. No definition available.
|
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Terminated in Period No definition available.
|
X | ||||||||||
- Definition Weighted average price per share for warrants terminated during the period. No definition available.
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Details
|